PureTech Health (LON:PRTC) Stock Crosses Above 50-Day Moving Average – Time to Sell?

PureTech Health plc (LON:PRTC)’s share price crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of GBX 128.96 and traded as high as GBX 131.60. PureTech Health shares last traded at GBX 129.60, with a volume of 246,026 shares.

PureTech Health Trading Down 0.3%

The company has a debt-to-equity ratio of 6.33, a current ratio of 6.59 and a quick ratio of 2.51. The company has a market capitalization of £316.44 million, a P/E ratio of -2.83 and a beta of 0.81. The firm has a fifty day moving average price of GBX 129.64 and a 200-day moving average price of GBX 126.58.

PureTech Health Company Profile

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia.